Insight Molecular Diagnostics Inc. (IMDX) vs Lucid Diagnostics Inc. (LUCD)
A side-by-side comparison of Insight Molecular Diagnostics Inc. and Lucid Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMDX
Insight Molecular Diagnostics Inc.
$3.64HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
LUCD
Lucid Diagnostics Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
Total return — IMDX vs LUCD
growth of $100 · dividends reinvested · last 5yIMDX -94.7% (-44.3%/yr)LUCD -95.0% (-45.0%/yr)IMDX compounded faster over this window
IMDX LUCD
IMDX vs LUCD: by the numbers
- •IMDX is the larger company ($117M vs $115M market cap).
- •Both run net losses; LUCD's is the smaller (-959.76% vs -2955.63% net margin).
Metrics side by side
Valuation
| Metric | IMDX | LUCD |
|---|---|---|
| P/S ratio | 70.28 | 21.14 |
| P/B ratio | N/A | 10.53 |
Profitability
| Metric | IMDX | LUCD |
|---|---|---|
| Gross margin | 11.17% | -60.26% |
| Operating margin | -754.08% | -1054.82% |
| Net margin | -2955.63% | -959.76% |
| ROE | N/A | -478.26% |
| ROIC | -223.06% | -145.10% |
Growth (annualized)
| Metric | IMDX | LUCD |
|---|---|---|
| Revenue CAGR (5Y) | 27.24% | N/A |
| Total return CAGR (5Y) | -44.39% | N/A |
Go deeper
Dig into the metrics
Insight Molecular Diagnostics ROELucid Diagnostics ROEInsight Molecular Diagnostics operating marginLucid Diagnostics operating marginInsight Molecular Diagnostics revenue growthLucid Diagnostics revenue growthInsight Molecular Diagnostics free cash flowLucid Diagnostics free cash flow
Insight Molecular Diagnostics & Lucid Diagnostics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.